Cargando…

Fragile X protein in newborn dried blood spots

BACKGROUND: The fragile X syndrome (FXS) results from mutation of the FMR1 gene that prevents expression of its gene product, FMRP. We previously characterized 215 dried blood spots (DBS) representing different FMR1 genotypes and ages with a Luminex-based immunoassay (qFMRP). We found variable FMRP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adayev, Tatyana, LaFauci, Giuseppe, Dobkin, Carl, Caggana, Michele, Wiley, Veronica, Field, Michael, Wotton, Tiffany, Kascsak, Richard, Nolin, Sarah L, Glicksman, Anne, Hosmer, Nicole, Brown, W Ted
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412103/ https://www.ncbi.nlm.nih.gov/pubmed/25348928 http://dx.doi.org/10.1186/s12881-014-0119-0

Ejemplares similares

Detection and Quantification of the Fragile X Mental Retardation Protein 1 (FMRP)
por: LaFauci, Giuseppe, et al.
Publicado: (2016)

Development of a Quantitative FMRP Assay for Mouse Tissue Applications
por: Adayev, Tatyana, et al.
Publicado: (2021)

Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots
por: Boggs, Anna E., et al.
Publicado: (2022)

Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety
por: Klusek, Jessica, et al.
Publicado: (2017)

A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments
por: Budimirovic, Dejan B., et al.
Publicado: (2020)

Are We Ready for Fragile X Newborn Screening Testing?—Lessons Learnt from a Feasibility Study
por: Wotton, Tiffany, et al.
Publicado: (2018)

Creatine kinase‐MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy
por: Park, Sunju, et al.
Publicado: (2022)

Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays
por: Dantonio, Paul, et al.
Publicado: (2023)

Eliciting parental support for the use of newborn blood spots for pediatric research
por: Yeung, Edwina H., et al.
Publicado: (2016)

A case study in citizen environmental humanities: creating a participatory plant story website
por: Gianquitto, Tina, et al.
Publicado: (2022)

The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome
por: Wei, Hongen, et al.
Publicado: (2012)

Newborn Dried Blood Spots for Serologic Surveys of COVID-19
por: Liu, Feimei, et al.
Publicado: (2020)

Improved Dried Blood Spot PCR Assay for Universal Congenital Cytomegalovirus Screening in Newborns
por: Kim, Jean H., et al.
Publicado: (2023)

Influence of Hematocrit and Total-Spot Volume on Performance Characteristics of Dried Blood Spots for Newborn Screening
por: Hall, Elizabeth M., et al.
Publicado: (2015)

Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021
por: Damjanovic, Amanda, et al.
Publicado: (2022)

Direct Derivatization in Dried Blood Spots for Oxidized and Reduced Glutathione Quantification in Newborns
por: Ten-Doménech, Isabel, et al.
Publicado: (2022)

Dried Blood Spot in Laboratory: Directions and Prospects
por: Malsagova, Kristina, et al.
Publicado: (2020)

Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles
por: Nolin, Sarah L., et al.
Publicado: (2019)

Refining the risk for fragile X–associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size
por: Allen, Emily Graves, et al.
Publicado: (2021)

Newborn dried blood spot samples in Denmark: the hidden figures of secondary use and research participation
por: Nordfalk, Francisca, et al.
Publicado: (2018)

Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
por: Gelb, Michael H., et al.
Publicado: (2018)

At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn Screening
por: Lukacs, Zoltan, et al.
Publicado: (2020)

Trace elements in dried blood spots as potential discriminating features for metabolic disorder diagnosis in newborns
por: Moreda-Piñeiro, Jorge, et al.
Publicado: (2021)

The view of Hong Kong parents on secondary use of dried blood spots in newborn screening program
por: Hui, L. L., et al.
Publicado: (2022)

Scalable, high quality, whole genome sequencing from archived, newborn, dried blood spots
por: Ding, Yan, et al.
Publicado: (2023)

Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy
por: Migliore, Brooke A., et al.
Publicado: (2022)

Multi-mycotoxin analysis using dried blood spots and dried serum spots
por: Osteresch, Bernd, et al.
Publicado: (2017)

Curvilinear Association Between Language Disfluency and FMR1 CGG Repeat Size Across the Normal, Intermediate, and Premutation Range
por: Klusek, Jessica, et al.
Publicado: (2018)

Tandem Mass Spectrometry Assays of Palmitoyl Protein Thioesterase 1 and Tripeptidyl Peptidase Activity in Dried Blood Spots for the Detection of Neuronal Ceroid Lipofuscinoses in Newborns
por: Barcenas, Mariana, et al.
Publicado: (2014)

Toward Newborn Screening of Cerebrotendinous Xanthomatosis: Results of a Biomarker Research Study Using 32,000 Newborn Dried Blood Spots
por: Hong, Xinying, et al.
Publicado: (2020)

A Single Common Assay for Robust and Rapid Fragile X Mental Retardation Syndrome Screening From Dried Blood Spots
por: Tan, Vivienne J., et al.
Publicado: (2018)

High performing male with fragile X syndrome with an unmethylated FMR1 full mutation: The relevance of clinical and genetic correlations
por: Shieh, Meg, et al.
Publicado: (2023)

Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?
por: White, Stephanie, et al.
Publicado: (2023)

Analysis of the TREC and KREC Levels in the Dried Blood Spots of Healthy Newborns with Different Gestational Ages and Weights
por: Cheremokhin, D. A., et al.
Publicado: (2022)

Efficient Delivery of FMR1 across the Blood Brain Barrier Using AAVphp Construct in Adult FMR1 KO Mice Suggests the Feasibility of Gene Therapy for Fragile X Syndrome
por: Chadman, Kathryn K., et al.
Publicado: (2023)

Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia
por: Grecsó, Nóra, et al.
Publicado: (2020)

Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia
por: Grecsó, Nóra, et al.
Publicado: (2021)

Exploring existing and deliberated community perspectives of newborn screening: informing the development of state and national policy standards in newborn screening and the use of dried blood spots
por: Muchamore, Ian, et al.
Publicado: (2006)

Preparation and processing of dried blood spots for microRNA sequencing
por: Morgunova, Alice, et al.
Publicado: (2023)

2335. Newborn Dried Blood Spot for Retrospective Diagnosis of Congenital Cytomegalovirus (CMV) Infection: It’s Time for Universal Screening!
por: Medoro, Alexandra K, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jrt1dmnj48gu09p5mfkej9bsn3